Stocktoria
CYPHERPUNK TECHNOLOGIES INC. CYPH
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-01-24
CYPHERPUNK TECHNOLOGIES INC. statistics & valuation
Market cap$65.8M
P / E13.7×
P / B0.4×
Return on equity3.1%
Return on capital-25.9%
Graham number +158.1%$1.70
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($1.70); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | -2761.7% | -1902.6% | — | — | — | — |
| Net margin | — | — | — | — | -2705.8% | -1834.3% | — | — | — | — |
| Return on assets | 3.0% | -137.5% | -111.8% | -77.6% | -34.4% | -50.6% | -441.7% | -121.3% | -102.3% | -397.0% |
| Return on equity | 3.1% | -192.7% | -135.4% | -92.7% | -37.6% | -59.0% | 1881.1% | -252.2% | -267.4% | 25.6% |
| Current ratio | 35.56 | 3.41 | 5.64 | 6.05 | 11.70 | 7.09 | 0.50 | 2.69 | 4.55 | 0.11 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.